Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Diffuse cutaneous leishmaniasis: a disease due to an immunological defect of the host.

× No keyword cloud information.

38 in total

1. Differential induction of cellular responses by live and dead Leishmania promastigotes in healthy donors.

Authors: S Nylén; U Mörtberg; D Kovalenko; I Satti; K Engström; M Bakhiet; H Akuffo
Journal: Clin Exp Immunol Date: 2001-04 Impact factor: 4.330

2. Effect of visceral leishmaniasis on congenitally athymic mice.

Authors: L L Smrkovski; C L Larson; S G Reed
Journal: Infect Immun Date: 1979-09 Impact factor: 3.441

3. Chronic heat-shock treatment driven differentiation induces apoptosis in Leishmania donovani.

Authors: Puneet Raina; Sukhbir Kaur
Journal: Mol Cell Biochem Date: 2006-07-11 Impact factor: 3.396

4. New Zealand black mice are immunologically resistant to high-dose, but not low-dose Leishmania mexicana infection.

Authors: R C Dorea; J Alexander; G Gallagher
Journal: Clin Exp Immunol Date: 1991-08 Impact factor: 4.330

5. Reappraisal of the immunopathogenesis of disseminated leishmaniasis: in situ and systemic immune response.

Authors: Paulo R Machado; Maria Elisa A Rosa; Diego Costa; Moema Mignac; João S Silva; Albert Schriefer; Mauro M Teixeira; Olivia Bacellar; Edgar M Carvalho
Journal: Trans R Soc Trop Med Hyg Date: 2011-07-02 Impact factor: 2.184

6. Histopathologic changes induced by vaccination in experimental cutaneous leishmaniasis of BALB/c mice.

Authors: M Barral-Netto; L A de Freitas; Z A Andrade
Journal: Am J Pathol Date: 1987-05 Impact factor: 4.307

7. Mechanisms associated with immunoregulation in human American cutaneous leishmaniasis.

Authors: M Castés; A Agnelli; A J Rondón
Journal: Clin Exp Immunol Date: 1984-08 Impact factor: 4.330

8. Leishmania pifanoi amastigote antigens protect mice against cutaneous leishmaniasis.

Authors: L Soong; S M Duboise; P Kima; D McMahon-Pratt
Journal: Infect Immun Date: 1995-09 Impact factor: 3.441

9. Mechanisms of immunity to leishmaniasis III. The development and decay of resistance during metastatic disease.

Authors: L W Poulter; M T Pearce
Journal: Clin Exp Immunol Date: 1980-11 Impact factor: 4.330

10. Characterization of an I-E-restricted, gp63-specific, CD4-T-cell clone from Leishmania major-resistant C3H mice that secretes type 2 cytokines and exacerbates infection with L. major.

Authors: Cynthia M Theodos; Robin V Morris; Jeanette V Bishop; Jeremy D Jones; W Robert McMaster; Richard G Titus
Journal: Infect Immun Date: 2004-08 Impact factor: 3.441